IGFBP5 and osteosarcoma: Increased expression of miR-140 could modulate cancer cell chemoresistance by targeting IGFBP-5 and sensitizes osteosarcoma cells to chemotherapy by promoting HMGN5-mediated autophagy [14, 15].